Encoded Nabs $104M, Illumina?s Help, to Push Gene Therapy?s Limits

Despite the progress of gene therapy?a cutting edge medicine promising long-lasting effects from a single treatment?it remains a crude and limited tool. Startup Encoded Therapeutics has raised $104 million to join the race to expand gene therapy?s reach. The South San Francisco, CA, company has emerged from the startup accelerator of Illumina (NASDAQ: ILMN), and [?]